Chung Lee, MD, the SPORE director, is assisted by co-directors William Catalona, MD and Walter Stadler, MD. Additional input is obtained through monthly meetings of the SPORE Executive Committee and quarterly meetings of the Internal Advisory Committee. An External Advisory Committee of nationally recognized leaders in prostate cancer provides guidance to the SPORE Program annually.

Research Projects:

1. 5-Alpha-Reductase Inhibition In Intermittent Androgen Ablation Therapy Of Prostate Cancer
   Zhou Wang, PhD, and Daniel Shevrin, MD
   
   
2. Adipocyte-derived soluble proteins as regulators of angiogenesis in prostate cancer
   Susan Crawford, M.D., Susan Gapstur, Ph.D., Chung Lee, Ph.D.
   
   
3. Radiation Inducible TNF-alpha Therapy in Prostate Cancer
   Ralph Weichselbaum, MD and Walter Stadler, MD
   
   
4. Modulation of Prostate Cancer Cell Motility by the Chemopreventive Agent Genistein
   Raymond Bergan, MD, and William Catalona, MD